Mitsubishi Tanabe Pharma issues its news to provide stakeholders with the latest information related to the Company. Information on products or drug candidates may be included, but is intended to provide for the media, etc. It is not intended for promotion, advertising or medical advice.
Information Humanitarian Donation to Ukraine
July 13, 2022
Mitsubishi Tanabe Pharma Corporation (MTPC, Head Office: Chuo-ku, Osaka; Representative Director: Hiroaki Ueno) donated drugs selected based on a drug list requested by the Ukraine Embassy in Japan through the Japan Pharmaceutical Manufacturers Association (JPMA) for the purpose of humanitarian support for the people of Ukraine and those who have no choice but to evacuate to neighboring countries.
The Mitsubishi Chemical Group has made a donation of EUR 1 million to the United Nations High Commissioner for Refugees (UNHCR).
MTPC sincerely hopes that this serious problem will be resolved, and the people of Ukraine will be able to resume their safe and peaceful lives as soon as possible.